Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Northern Ireland Test Vaccinate or Remove Badger Intervention trial

PROVIDER: PRJNA925930 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR23174000_1.fastq.gz	Fastqsanger.gz
	SRR23174000_2.fastq.gz	Fastqsanger.gz
	SRR23174100_1.fastq.gz	Fastqsanger.gz
	SRR23174100_2.fastq.gz	Fastqsanger.gz
	SRR23174200_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1206

Similar Datasets

Project description:Northern Ireland Brucella abortus

| PRJNA576561 | ENA

A randomised controlled trial of folic acid intervention in pregnancy highlights a putative methylation-regulated control element at ZFP57

Project description:Background: Maternal blood folate concentrations during pregnancy have been previously linked with DNA methylation patterns, but this has been done predominantly through observational studies. We showed recently in an epigenetic analysis of the first randomized controlled trial (RCT) of folic acid supplementation specifically in the second and third trimesters (the EpiFASSTT trial) that methylation at some imprinted genes was altered in cord blood samples in response to treatment. Here, we report on epigenome-wide screening using the Illumina EPIC array (~ 850,000 sites) in these same samples (n = 86). Results: The top-ranked differentially methylated promoter region (DMR) showed a gain in methylation with folic acid (FA) and was located upstream of the imprint regulator ZFP57. Differences in methylation in cord blood between placebo and folic acid treatment groups at this DMR were verified using pyrosequencing. The DMR also gains methylation in maternal blood in response to FA supplementation. We also found evidence of differential methylation at this region in an independent RCT cohort, the AFAST trial. By altering methylation at this region in two model systems in vitro, we further demonstrated that it was associated with ZFP57 transcription levels. Conclusions: These results strengthen the link between folic acid supplementation during later pregnancy and epigenetic changes and identify a novel mechanism for regulation of ZFP57. This trial was registered 15 May 2013 at www.isrctn.com as ISRCTN19917787. Ethics approval and consent to participate: The Office for Research and Ethics Committees Northern Ireland (ORECNI) granted ethical approval (reference 05/ Q2008/21) and each participant gave written informed consent upon recruitment.

2021-06-08 | GSE176325 | GEO

WGS for routine Mycobacterium bovis epidemiology Northern Ireland

Project description:WGS for routine Mycobacterium bovis epidemiology Northern Ireland

| PRJEB65421 | ENA

Interventions to Improve Bowel Cancer Screening Uptake in Ireland: a 2x2 Factorial Trial

Project description:High uptake is vital to population-based screening. BowelScreen (Irelands national organised population-based colorectal cancer screening programme) has not achieved recommended screening uptake targets. In Ireland sending the test kit in the screening invitation reminder may be an important strategy in targeting non-responders and would address a key difference between Ireland and other international screening programmes with higher uptake. In addition, few studies have focused on behavioural barriers to screening participation. Founded upon the MRC Guidelines for the Development of Complex Interventions, our systematic, theoretically-informed investigation of FIT screening participation has begun to identify behavioural antecedents to screening participation in Ireland. This study will implement a multilevel evidence-based, theoretically-informed intervention which includes the automatic inclusion of the test kit in the screening reminder, alone and in combination with an intervention to influence individuals’ screening participation. This multilevel intervention will provide recommendations for the screening invitation delivery, potentially bringing the programme closer to recommended uptake targets (50%) and in the long-term influence reductions in bowel cancer incidence and mortality in Ireland.

| 2760785 | ecrin-mdr-crc

remove

Project description:remove

| PRJEB54674 | ENA

An Evolutionary Cancer Epigenetic approach revealed DNA hypermethylation of Ultra-Conserved Non-coding Elements in squamous cell carcinoma of different mammalian species

Project description:Background: Ultra-Conserved-Non-coding Elements (UCNEs) are genomic sequences that exhibit >95% sequence identity between human, mammals, birds, reptiles and fishes. Recent findings reported their functional role in cancer. Aim of this study was to evaluate their DNA methylation modifications in squamous cell carcinoma (SCC) from different mammal species Methods: Fifty SCC from 26 humans, 17 cats, 3 dogs, 1 horse, 1 bovine, 1 badger and 1 porcupine were investigated. Fourteen feline stomatitis and normal samples from 36 healthy human donors, 7 cats, 5 dogs, 5 horses, 2 bovines and 1 badger were collected as normal controls. Bisulfite Next Generation Sequencing evaluated the DNA methylation level from seven UCNEs (uc.160, uc.283, uc.416, uc.339, uc.270, uc.299, uc.328). Results: 57/59 CpGs were significantly different according to the Kruskal-Wallis test (P<0.05) comparing normal vs SCC. A common DNA hypermethylation pattern was observed in SCC from all the species evaluated in this study, with an increasing trend of hypermethylation starting from normal mucosa, through stomatitis to SCC. Conclusions: Our findings indicate that UCNEs are hypermethylated in human SCC, and this behavior is also conserved among different species of mammals.

2020-09-04 | GSE157436 | GEO

Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)

Project description:Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)

| PRJNA1047941 | ENA

Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)

Project description:Systolic Blood Pressure Intervention Trial (SPRINT-BioLINCC)

| PRJNA1047942 | ENA

Systolic Blood Pressure Intervention Trial (SPRINT-Imaging)

Project description:Systolic Blood Pressure Intervention Trial (SPRINT-Imaging)

| PRJNA1079434 | ENA

Project description:Badger virome

| PRJNA1017832 | ENA